InsiderClue
← All stocks

Roivant Sciences Ltd.

ROIV Net selling
CIK 0001635088 #653 in the set updated 17 Sep 2026
Bought (120 mo)
$20.20M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.26B
$10.61M on a plan · $544.72M straight out of an exercise
Sold at will
$1.70B
164 of 288 sales
Net
−$2.24B
−$1.68B against sales at will

By person

21 insiders · 293 transactions
916×

Matthew Gline holds 916 times base salary in stock. $664.73M of shares against $725.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Matthew Gline last reported holding, valued at $39.90, the price Common Shares was last bought or sold at on the open market here, on 8 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Gold Daniel Allen
Director
—
$341.57M (36)
−$341.57M
22,649,927
3.14%
$903.73M
−82.9%
QVT Financial LP entity
Director by Deputization
—
$300.69M (32)
−$300.69M
13,689,166
1.90%
$546.20M
−88.6%
MANCHESTER KEITH S
Director
—
$258.62M (30)
−$258.62M
15,437,569
2.14%
$615.96M
−81.0%
SVF Investments (UK) Ltd entity
10% owner
—
$242.63M (3)
−$242.63M
73,031,667
10.11%
$2.91B
−26.5%
Ramaswamy Vivek
10% owner
—
$224.96M (17)
−$224.96M
47,011,612
6.51%
$1.88B
−21.5%
Venker Eric
President & Immunovant CEO
—
$200.44M (90) scheduled
−$200.44M
1,599,154
0.2214%
$63.81M
+15.1%
Sumitomo Chemical Co., Ltd. entity
10% owner
—
$130.00M (1)
−$130.00M
71,251,083
9.86%
$2.84B
−17.5%
VIKING GLOBAL INVESTORS LP entity
10% owner
—
$128.70M (4)
−$128.70M
12,884,307
1.78%
$514.08M
−50.2%
VIKING GLOBAL PERFORMANCE LLC entity
10% owner
—
$128.70M (4)
−$128.70M
12,884,307
1.78%
$514.08M
−50.2%
Sukhatme Mayukh
President & CIO
—
$124.75M (17) scheduled
−$124.75M
18,630,739
2.58%
$743.37M
+515.9%
Torti Frank
President and Vant Chair
—
$82.04M (3) scheduled
−$82.04M
13,536,202
1.87%
$540.09M
—
Gline Matthew
CEO
$49.96K (1)
$71.78M (16) scheduled
−$71.73M
16,659,945
2.31%
$664.73M
+890.7%
Dexcel Pharma Technologies Ltd. entity
10% owner
$20.15M (3)
—
+$20.15M
102,849,443
14.24%
$4.10B
+4.1%
Kumar Rakhi
Chief Accounting Officer
—
$9.87M (25) scheduled
−$9.87M
162,306
0.0225%
$6.48M
−38.8%
Pulik Richard
CFO
—
$9.14M (3) scheduled
−$9.14M
271,810
0.0376%
$10.85M
+16.1%
Fitzgerald Meghan
Director
—
$3.07M (3) scheduled
−$3.07M
41,220
0.0057%
$1.64M
—
Epperly Melissa B,
Director
—
$1.81M (3)
−$1.81M
14,838
0.0021%
$592.04K
—
Humes Jennifer
Chief Accounting Officer
—
$384.07K (1)
−$384.07K
109,782
0.0152%
$4.38M
—
Oren Ilan
Director
—
—
—
118,626
0.0164%
$4.73M
—
MOMTAZEE JAMES C
Director
—
—
—
106,905
0.0148%
$4.27M
—
Lo Andrew
Director
—
—
—
52,142
0.0072%
$2.08M
—

Individual transactions

122
Insider
Date
Role
Action
Shares
Price
Amount
Fitzgerald Meghan
8 Sep 2026
Director
Sold after exercise
20,000
$39.90
$798.00K
Venker Eric
28 Aug 2026
President & Immunovant CEO
Sold after exercise
33,818
$36.44
$1.23M
Venker Eric
28 Aug 2026
President & Immunovant CEO
Sold after exercise
166,182
$35.63
$5.92M
Sukhatme Mayukh
21 Aug 2026
President & CIO
Sold after exercise
144,756
$36.48
$5.28M
Sukhatme Mayukh
20 Aug 2026
President & CIO
Sold after exercise
17,519
$37.30
$653.46K
Sukhatme Mayukh
19 Aug 2026
President & CIO
Sold after exercise
172,899
$37.17
$6.43M
Sukhatme Mayukh
18 Aug 2026
President & CIO
Sold after exercise
31,801
$37.18
$1.18M
Sukhatme Mayukh
18 Aug 2026
President & CIO
Sold after exercise
105,141
$36.59
$3.85M
Sukhatme Mayukh
17 Aug 2026
President & CIO
Sold after exercise
284,707
$36.25
$10.32M
Sukhatme Mayukh
14 Aug 2026
President & CIO
Sold after exercise
243,177
$36.23
$8.81M
Venker Eric
27 Jul 2026
President & Immunovant CEO
Sold after exercise
200,000
$34.95
$6.99M
Fitzgerald Meghan
30 Jun 2026
Director
Sold after exercise
10,000
$34.90
$349.00K
Epperly Melissa B,
29 Jun 2026
Director
Sold after exercise
2,748
$34.71
$95.38K
Epperly Melissa B,
29 Jun 2026
Director
Sold after exercise
15,002
$34.32
$514.87K
Sukhatme Mayukh
26 Jun 2026
President & CIO
Sold after exercise
500,000
$34.08
$17.04M
Sukhatme Mayukh
25 Jun 2026
President & CIO
Sold after exercise
500,000
$34.13
$17.07M
Venker Eric
24 Jun 2026
President & Immunovant CEO
Sold after exercise
46,234
$33.51
$1.55M
Venker Eric
24 Jun 2026
President & Immunovant CEO
Sold after exercise
153,766
$33.05
$5.08M
Venker Eric
22 May 2026
President & Immunovant CEO
Sold after exercise
200,000
$30.27
$6.05M
Venker Eric
20 Apr 2026
President & Immunovant CEO
Sold after exercise
200,000
$29.59
$5.92M
Fitzgerald Meghan
26 Mar 2026
Director
Sold after exercise
70,000
$27.45
$1.92M
Venker Eric
17 Mar 2026
President & Immunovant CEO
Sold after exercise
200,000
$28.24
$5.65M
Torti Frank
23 Feb 2026
President and Vant Chair
Sold after exercise
587,390
$27.51
$16.16M
Torti Frank
20 Feb 2026
President and Vant Chair
Sold after exercise
1,012,610
$27.15
$27.49M
Torti Frank
19 Feb 2026
President and Vant Chair
Sold after exercise
1,400,000
$27.42
$38.39M
Venker Eric
13 Feb 2026
President & Immunovant CEO
Sold after exercise
200,000
$26.49
$5.30M
Sukhatme Mayukh
9 Feb 2026
President & CIO
Sold after exercise
339,441
$26.47
$8.99M
Venker Eric
12 Jan 2026
President & Immunovant CEO
Sold after exercise
200,000
$21.92
$4.38M
Sukhatme Mayukh
31 Dec 2025
President & CIO
Sold after exercise
1,018,995
$21.71
$22.12M
Sukhatme Mayukh
29 Dec 2025
President & CIO
Sold after exercise
311,873
$21.74
$6.78M
Venker Eric
24 Dec 2025
President & Immunovant CEO
Sold after exercise
75,000
$22.53
$1.69M
Venker Eric
23 Dec 2025
President & Immunovant CEO
Sold after exercise
200,000
$22.45
$4.49M
Pulik Richard
23 Dec 2025
CFO
Sold after exercise
146,731
$22.39
$3.29M
Pulik Richard
23 Dec 2025
CFO
Sold after exercise
260,000
$22.45
$5.84M
Sukhatme Mayukh
17 Dec 2025
President & CIO
Sold after exercise
26,831
$23.09
$619.53K
Ramaswamy Vivek
15 Dec 2025
10% owner
Sold after exercise
353,745
$22.05
$7.80M
Gline Matthew
15 Dec 2025
CEO
Sold after exercise
943,527
$21.68
$20.46M
Gline Matthew
15 Dec 2025
CEO
Sold after exercise
566,116
$21.68
$12.27M
Gline Matthew
15 Dec 2025
CEO
Sold after exercise
230,357
$21.68
$4.99M
Ramaswamy Vivek
12 Dec 2025
10% owner
Sold after exercise
1,975,858
$21.96
$43.39M
Ramaswamy Vivek
11 Dec 2025
10% owner
Sold after exercise
774,142
$21.64
$16.75M
Venker Eric
9 Dec 2025
President & Immunovant CEO
Sold after exercise
200,000
$20.85
$4.17M
Venker Eric
7 Nov 2025
President & Immunovant CEO
Sold after exercise
200,000
$20.22
$4.04M
Venker Eric
17 Oct 2025
President & Immunovant CEO
Sold after exercise
118,418
$17.06
$2.02M
Venker Eric
16 Oct 2025
President & Immunovant CEO
Sold after exercise
318,282
$17.05
$5.43M
Venker Eric
15 Oct 2025
President & Immunovant CEO
Sold after exercise
414,683
$16.93
$7.02M
Venker Eric
13 Oct 2025
President & Immunovant CEO
Sold after exercise
20,727
$16.25
$336.81K
Venker Eric
9 Oct 2025
President & Immunovant CEO
Sold after exercise
104,940
$16.30
$1.71M
Venker Eric
8 Oct 2025
President & Immunovant CEO
Sold after exercise
138,602
$16.20
$2.25M
Venker Eric
7 Oct 2025
President & Immunovant CEO
Sold after exercise
355,161
$16.15
$5.74M
Venker Eric
6 Oct 2025
President & Immunovant CEO
Sold after exercise
171,396
$16.34
$2.80M
Venker Eric
22 Sep 2025
President & Immunovant CEO
Sold after exercise
100,000
$15.01
$1.50M
Venker Eric
22 Sep 2025
President & Immunovant CEO
Sold after exercise
316,182
$14.99
$4.74M
Venker Eric
19 Sep 2025
President & Immunovant CEO
Sold after exercise
683,818
$14.95
$10.22M
Venker Eric
20 Aug 2025
President & Immunovant CEO
Sold after exercise
100,000
$11.72
$1.17M
Venker Eric
21 Jul 2025
President & Immunovant CEO
Sold after exercise
100,000
$11.52
$1.15M
Venker Eric
20 Jun 2025
President & COO
Sold after exercise
100,000
$11.45
$1.15M
Venker Eric
3 Jun 2025
President & COO
Sold after exercise
566,278
$11.22
$6.35M
Venker Eric
2 Jun 2025
President & COO
Sold after exercise
433,722
$11.07
$4.80M
Venker Eric
20 May 2025
President & COO
Sold after exercise
100,000
$10.95
$1.10M
Venker Eric
21 Apr 2025
President & COO
Sold after exercise
100,000
$10.22
$1.02M
Venker Eric
24 Mar 2025
President & COO
Sold after exercise
434,478
$10.82
$4.70M
Venker Eric
20 Mar 2025
President & COO
Sold after exercise
315,522
$11.06
$3.49M
Venker Eric
20 Feb 2025
President & COO
Sold after exercise
100,000
$10.65
$1.07M
Venker Eric
13 Feb 2025
President & COO
Sold after exercise
218,041
$10.42
$2.27M
Kumar Rakhi
13 Feb 2025
Chief Accounting Officer
Sold after exercise
227,500
$10.43
$2.37M
Venker Eric
12 Feb 2025
President & COO
Sold after exercise
217,384
$10.53
$2.29M
Venker Eric
21 Jan 2025
President & COO
Sold after exercise
100,000
$11.28
$1.13M
Venker Eric
30 Dec 2024
President & COO
Sold after exercise
177,704
$11.54
$2.05M
Venker Eric
27 Dec 2024
President & COO
Sold after exercise
176,900
$11.82
$2.09M
Sukhatme Mayukh
26 Dec 2024
Pres&Chief Investment Officer
Sold after exercise
689,495
$12.01
$8.28M
Sukhatme Mayukh
24 Dec 2024
Pres&Chief Investment Officer
Sold after exercise
185,946
$12.00
$2.23M
Sukhatme Mayukh
23 Dec 2024
Pres&Chief Investment Officer
Sold after exercise
10,796
$12.00
$129.55K
Venker Eric
20 Dec 2024
President & COO
Sold after exercise
100,000
$11.49
$1.15M
Sukhatme Mayukh
18 Dec 2024
Pres&Chief Investment Officer
Sold after exercise
412,584
$12.05
$4.97M
Venker Eric
20 Nov 2024
President & COO
Sold after exercise
100,000
$11.32
$1.13M
Venker Eric
21 Oct 2024
President & COO
Sold after exercise
100,000
$11.65
$1.17M
Kumar Rakhi
23 Sep 2024
Chief Accounting Officer
Sold after exercise
250,000
$11.89
$2.97M
Gline Matthew
23 Sep 2024
CEO
Sold after exercise
1,983,257
$11.79
$23.38M
Venker Eric
9 Feb 2024
President & COO
Sold after exercise
96,950
$10.92
$1.06M
Venker Eric
3 Oct 2023
Chief Operating Officer
Sold after exercise
606,221
$10.25
$6.21M
Venker Eric
2 Oct 2023
Chief Operating Officer
Sold after exercise
440,752
$10.80
$4.76M
Venker Eric
27 Sep 2023
President & COO
Sold after exercise
500,000
$13.02
$6.51M
Kumar Rakhi
8 Sep 2023
Chief Accounting Officer
Sold after exercise
99,350
$12.18
$1.21M
Venker Eric
8 Sep 2023
Chief Operating Officer
Sold after exercise
106,430
$12.19
$1.30M
Venker Eric
6 Sep 2023
Chief Operating Officer
Sold after exercise
5,926
$11.85
$70.22K
Venker Eric
5 Sep 2023
Chief Operating Officer
Sold after exercise
73,275
$11.92
$873.44K
Kumar Rakhi
5 Sep 2023
Chief Accounting Officer
Sold after exercise
1,724
$12.00
$20.69K
Venker Eric
1 Sep 2023
Chief Operating Officer
Sold after exercise
14,763
$11.90
$175.68K
Venker Eric
14 Aug 2023
Chief Operating Officer
Sold after exercise
59,811
$11.89
$711.15K
Kumar Rakhi
3 Aug 2023
Chief Accounting Officer
Sold after exercise
3,681
$12.00
$44.17K
Venker Eric
3 Aug 2023
Chief Operating Officer
Sold after exercise
44,629
$11.93
$532.42K
Venker Eric
2 Aug 2023
Chief Operating Officer
Sold after exercise
16,397
$11.86
$194.47K
Venker Eric
1 Aug 2023
Chief Operating Officer
Sold after exercise
61,397
$11.92
$731.85K
Kumar Rakhi
1 Aug 2023
Chief Accounting Officer
Sold after exercise
336
$12.00
$4.03K
Venker Eric
31 Jul 2023
Chief Operating Officer
Sold after exercise
117,372
$11.91
$1.40M
Venker Eric
27 Jul 2023
Chief Operating Officer
Sold after exercise
23,622
$10.98
$259.37K
Venker Eric
26 Jul 2023
Chief Operating Officer
Sold after exercise
73,568
$10.91
$802.63K
Venker Eric
25 Jul 2023
Chief Operating Officer
Sold after exercise
28,344
$10.86
$307.82K
Venker Eric
24 Jul 2023
President & COO
Sold after exercise
33,081
$10.93
$361.58K
Venker Eric
21 Jul 2023
President & COO
Sold after exercise
181,998
$11.13
$2.03M
Venker Eric
20 Jul 2023
President & COO
Sold after exercise
159,387
$11.31
$1.80M
Kumar Rakhi
18 Jul 2023
Chief Accounting Officer
Sold after exercise
100
$12.00
$1.20K
Kumar Rakhi
14 Jul 2023
Chief Accounting Officer
Sold after exercise
535
$12.00
$6.42K
Venker Eric
9 Jun 2023
President & COO
Sold after exercise
299,384
$9.91
$2.97M
Kumar Rakhi
9 Jun 2023
Chief Accounting Officer
Sold after exercise
43,893
$9.93
$435.86K
Venker Eric
7 Jun 2023
President & COO
Sold after exercise
201
$9.85
$1.98K
Venker Eric
23 May 2023
President & COO
Sold after exercise
415
$9.85
$4.09K
Venker Eric
9 May 2023
President & COO
Sold after exercise
238,724
$9.23
$2.20M
Venker Eric
8 May 2023
President & COO
Sold after exercise
61,206
$8.93
$546.57K
Venker Eric
4 May 2023
President & COO
Sold after exercise
88,838
$8.30
$737.36K
Venker Eric
3 May 2023
President & COO
Sold after exercise
118,760
$8.40
$997.58K
Kumar Rakhi
2 May 2023
Chief Accounting Officer
Sold after exercise
15,517
$8.42
$130.65K
Venker Eric
2 May 2023
President & COO
Sold after exercise
109,074
$8.29
$904.22K
Kumar Rakhi
1 May 2023
Chief Accounting Officer
Sold after exercise
62,219
$8.58
$533.84K
Venker Eric
1 May 2023
President & COO
Sold after exercise
61,155
$8.59
$525.32K
Venker Eric
28 Apr 2023
President & COO
Sold after exercise
75,823
$8.47
$642.22K
Kumar Rakhi
28 Apr 2023
Chief Accounting Officer
Sold after exercise
71,989
$8.47
$609.75K
Venker Eric
27 Apr 2023
President & COO
Sold after exercise
73,514
$8.51
$625.60K
Kumar Rakhi
27 Apr 2023
Chief Accounting Officer
Sold after exercise
70,969
$8.51
$603.95K
Venker Eric
26 Apr 2023
President & COO
Sold after exercise
72,906
$8.66
$631.37K
Kumar Rakhi
26 Apr 2023
Chief Accounting Officer
Sold after exercise
87,830
$8.68
$762.36K
Showing 250 of 293 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 417
Amendments (4/A) skipped 0
Filings about a different issuer 34
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 122
Sales at will 164
Transactions with no price 0
Shares from compensation/vesting 352,725,463
Sales filed before the plan box existed 53
History held since 17 Oct 2017